PHARMA-BIO SERV, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
PHARMA-BIO SERV, INC. (PBSV) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $0 for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-09-14
- PHARMA-BIO SERV, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-07-31 was $0.00, a 100.00% decline year-over-year.
- PHARMA-BIO SERV, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-04-30 was $0.00, a 100.00% decline year-over-year.
- PHARMA-BIO SERV, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-01-31 was $29.39K, a 28.99% decline year-over-year.
- PHARMA-BIO SERV, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-10-31 was $43.36K, a 6.83% increase year-over-year.
- PHARMA-BIO SERV, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $169.21K, a 7.19% increase from fiscal 2024.
- PHARMA-BIO SERV, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $157.85K, a 7.94% increase from fiscal 2023.
- PHARMA-BIO SERV, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $146.24K, a 6.52% increase from fiscal 2022.
- PHARMA-BIO SERV, INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $137.28K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-07-31 | $0.00 10-Q · filed 2026-09-14 | $0.00 derived: sum of 2 quarters · filed 2026-09-14 | $29.39K 10-Q · filed 2026-09-14 | $72.75K derived: sum of 4 quarters · filed 2026-09-14 |
| 2026-04-30 | $0.00 10-Q · filed 2026-06-15 | $29.39K 10-Q · filed 2026-06-15 | $72.75K derived: sum of 3 quarters · filed 2026-06-15 | $115.26K derived: sum of 4 quarters · filed 2026-09-14 |
| 2026-01-31 | $29.39K 10-Q · filed 2026-03-17 | $72.75K derived: sum of 2 quarters · filed 2026-03-17 | $115.26K derived: sum of 3 quarters · filed 2026-09-14 | $157.21K derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-10-31 | $43.36K derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-29 | $85.87K derived: sum of 2 quarters · filed 2026-09-14 | $127.82K derived: sum of 3 quarters · filed 2026-09-14 | $169.21K 10-K · filed 2026-01-29 |
| 2025-07-31 | $42.51K 10-Q · filed 2026-09-14 | $84.46K derived: sum of 2 quarters · filed 2026-09-14 | $125.85K 10-Q · filed 2026-09-14 | $166.44K derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-04-30 | $41.95K 10-Q · filed 2026-06-15 | $83.34K 10-Q · filed 2026-06-15 | $123.92K derived: sum of 3 quarters · filed 2026-06-15 | $163.73K derived: sum of 4 quarters · filed 2026-06-15 |
| 2025-01-31 | $41.39K 10-Q · filed 2026-03-17 | $81.97K derived: sum of 2 quarters · filed 2026-03-17 | $121.78K derived: sum of 3 quarters · filed 2026-03-17 | $160.95K derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-10-31 | $40.59K derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-29 | $80.39K derived: sum of 2 quarters · filed 2026-01-29 | $119.56K derived: sum of 3 quarters · filed 2026-01-29 | $157.85K 10-K · filed 2026-01-29 |
| 2024-07-31 | $39.81K 10-Q · filed 2025-09-15 | $78.98K derived: sum of 2 quarters · filed 2025-09-15 | $117.27K 10-Q · filed 2025-09-15 | $154.82K derived: sum of 4 quarters · filed 2025-09-15 |
| 2024-04-30 | $39.17K 10-Q · filed 2025-06-16 | $77.46K 10-Q · filed 2025-06-16 | $115.01K derived: sum of 3 quarters · filed 2025-06-16 | $151.85K derived: sum of 4 quarters · filed 2025-06-16 |
| 2024-01-31 | $38.29K 10-Q · filed 2025-03-17 | $75.84K derived: sum of 2 quarters · filed 2025-03-17 | $112.68K derived: sum of 3 quarters · filed 2025-03-17 | $149.09K derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-10-31 | $37.55K derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-29 | $74.39K derived: sum of 2 quarters · filed 2025-01-29 | $110.80K derived: sum of 3 quarters · filed 2025-01-29 | $146.24K 10-K · filed 2025-01-29 |
| 2023-07-31 | $36.83K 10-Q · filed 2024-09-16 | $73.25K derived: sum of 2 quarters · filed 2024-09-16 | $108.68K 10-Q · filed 2024-09-16 | |
| 2023-04-30 | $36.42K 10-Q · filed 2024-06-14 | $71.85K 10-Q · filed 2024-06-14 | ||
| 2023-01-31 | $35.43K 10-Q · filed 2024-03-18 | |||
| 2022-10-31 | $137.28K 10-K · filed 2024-01-29 |